<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02667119</url>
  </required_header>
  <id_info>
    <org_study_id>16-101-2</org_study_id>
    <secondary_id>K23DA034879</secondary_id>
    <nct_id>NCT02667119</nct_id>
  </id_info>
  <brief_title>Integrated Treatment for Posttraumatic Stress Disorder and Substance Abuse in Young Adults</brief_title>
  <official_title>Treating Co-Occurring PTSD and Substance Abuse in High-Risk Transition Age Youth</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UConn Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>UConn Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the safety and efficacy of an integrated treatment&#xD;
      for substance abuse and posttraumatic stress disorder for young adults. The integrated&#xD;
      treatment includes two established psychosocial treatments for substance abuse (Contingency&#xD;
      Management) and posttraumatic stress disorder (Prolonged Exposure therapy).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">June 16, 2021</completion_date>
  <primary_completion_date type="Actual">June 16, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in severity of posttraumatic stress disorder symptoms as measured by the National Stressful Events PTSD Scale</measure>
    <time_frame>Baseline and 3- and 6-months post-baseline, weekly for 10 weeks of treatment phase</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Longest duration of abstinence from illicit drugs (physiological measure - urine drug screens)</measure>
    <time_frame>10 week treatment period</time_frame>
    <description>Illicit drug use is assessed twice weekly during the 10 week treatment period. Longest duration of abstinence is calculated as the longest time period of consecutive negative urine drug screens for illicit drugs during the 10 weeks of treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in severity of depression symptoms as measured by the Center for Epidemiological Studies-Depressed Mood scale</measure>
    <time_frame>Baseline and 3- and 6-month post-baseline, weekly for 10 weeks of the treatment phase</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in criminal behavior as measured by the Self-Reported Offending Scale</measure>
    <time_frame>Baseline and 3- and 6-month post-baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life as measured by the Quality of Life Scale</measure>
    <time_frame>Baseline and 3- and 6-month post-baseline</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Substance Use Disorder</condition>
  <condition>Posttraumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>Prolonged Exposure + Contingency Management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard services plus Prolonged Exposure and Contingency Management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard substance abuse treatment services</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Prolonged Exposure with Contingency Management</intervention_name>
    <description>Prolonged Exposure therapy for posttraumatic stress disorder includes psychoeducation, breathing retraining, in vivo exposure, and imaginal exposure.&#xD;
Contingency Management for substance abuse disorders: participants will have the chance to win prizes for each negative urine drug screen/breathalyzer provided.</description>
    <arm_group_label>Prolonged Exposure + Contingency Management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard Care</intervention_name>
    <description>Standard care will consist of treatment as usual in a community-based substance use treatment center.</description>
    <arm_group_label>Prolonged Exposure + Contingency Management</arm_group_label>
    <arm_group_label>Standard Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-25 years old&#xD;
&#xD;
          -  meets diagnostic criteria for substance use disorder&#xD;
&#xD;
          -  meets diagnostic criteria for full or subthreshold posttraumatic stress disorder&#xD;
&#xD;
          -  currently able to provide a urine drug screen that is negative for cocaine,&#xD;
             prescription opiates, and non-prescribed methadone or provided this type of screen in&#xD;
             the past 60 days&#xD;
&#xD;
          -  speaks English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  significant cognitive impairment or serious uncontrolled psychiatric problem (other&#xD;
             than posttraumatic stress disorder)&#xD;
&#xD;
          -  in recovery from pathological gambling or current pathological gambling diagnosis&#xD;
&#xD;
          -  in a current domestic violence relationship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristyn Zajac, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UConn Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UConn Health</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Village for Families and Children - Adult Services</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Farrell Treatment Center</name>
      <address>
        <city>New Britain</city>
        <state>Connecticut</state>
        <zip>06050</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Zajac K, Sheidow AJ, Davis M. Juvenile Justice, Mental Health, and the Transition to Adulthood: A Review of Service System Involvement and Unmet Needs in the U.S. Child Youth Serv Rev. 2015 Sep 1;56:139-148.</citation>
    <PMID>26273119</PMID>
  </reference>
  <reference>
    <citation>Zajac K, Randall J, Swenson CC. Multisystemic Therapy for Externalizing Youth. Child Adolesc Psychiatr Clin N Am. 2015 Jul;24(3):601-16. doi: 10.1016/j.chc.2015.02.007. Epub 2015 Mar 29. Review.</citation>
    <PMID>26092742</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 19, 2016</study_first_submitted>
  <study_first_submitted_qc>January 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2016</study_first_posted>
  <last_update_submitted>June 28, 2021</last_update_submitted>
  <last_update_submitted_qc>June 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UConn Health</investigator_affiliation>
    <investigator_full_name>Kristyn Zajac</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

